100 Reasons to Invest In Cellmid, page-70

Not worried by what the company is doing, how they are going about it, or who is in charge, and who is involved.
Have any of the fundamentals changed?
Actually I think they have improved their revenue a lot lately through Evolis and are on the verge of breaking even or better. I think a run into the US will greatly improve this.
We have been led to believe that this will occur in this FY.
The share price and accordingly the Market Cap are a bit on the low side for a biotech at this stage of development.
One asks why?
Lack of public knowledge?
Maybe every Evolis pack should have a small blurb about the company and what else it does.
"Buy Evolis and help beat cancer"
Newsletters are useful but aren't they really preaching to the converted. A bit about Midkine tucked in all those TV ads might help, even subliminally flashing the word.
Pretty soon half the nation will be looking up Midkine on Google. LOL
Cheers